EAACI Congress 2024

31 May - 03 June 2024 Valencia, Spain

L-TPS05 - Allergen immunotherapy 6

Saturday 01 Jun, 12:00 PM - 13:00 PM Valencia, Spain
Poster Zone Thematic Poster Session
Allergen immunotherapy (AIT) in pregnancy, focus on the use of carbamylated monomeric allergoid
Chicken egg allergy: development of new egg white allergoids
Facilitated antigen-presentation assays indicate differences in IgE-cross-blocking of antibodies following SLIT with recombinant Bet v 1 or Mal d 1
How allergists around the world perceive innovation in the context of allergen Immunotherapy AIT: an international survey
Hypoallergenic and anti-remodeling effect of a hybrid protein in a murine model of chronic asthma induced by Dermatophagoides pteronyssinus
Mannan-allergoids for food allergies: Production and characterization of peanut extracts treated with glutaraldehyde
Production and characterization of casein-rich allergoids aimed to treat cow’s milk persistent allergy
Respiratory allergy care pathway: patient’s perspective
TAPAS - a long-term non-interventional study evaluating MCT (MicroCrystalline Tyrosine)-associated allergoids shows non-inferiority of clinical effectiveness in children compared to adults during a 3-year course of allergen immunotherapy